Viewing StudyNCT03666832



Ignite Creation Date: 2024-05-06 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03666832
Status: UNKNOWN
Last Update Posted: 2022-06-15
First Post: 2018-09-10

Brief Title: Multi-center Open-label Phase 1b Clinical Trial to Evaluate the Safety Tolerability and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel
Sponsor: Joon Oh Park
Organization: Samsung Medical Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-06-17
Start Date Type: ACTUAL
Primary Completion Date: 2022-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2018-09-10
First Submit QC Date: September 11 2018
Study First Post Date: 2018-09-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-13
Last Update Post Date: 2022-06-15
Last Update Post Date Type: ACTUAL